FOSTER CITY, Calif., April 20, 2018 -- QuinStreet, Inc. (Nasdaq:QNST), a leader in performance marketing products and technologies, today announced that it will present at the upcoming Needham Emerging Technology Conference on May 15, 2018 at 10 a.m ET at the Westin Grand Central Hotel in New York City.
QuinStreet management will also be available for one-on-one meetings.
The Company looks forward to discussing the details of its performance momentum, market opportunity, and business model with investors.
About QuinStreet
QuinStreet, Inc. (Nasdaq:QNST) is one of the largest Internet performance marketing and media companies in the world. QuinStreet is committed to providing consumers and businesses with the information they need to research, find and select the products, services and brands that meet their needs. For more information, please visit www.QuinStreet.com.
Investor Contact
Erica Abrams
(415) 297-5864
[email protected]


Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 



